pRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels - PubMed (original) (raw)
. 2000 Aug 10;19(34):3878-87.
doi: 10.1038/sj.onc.1203722.
Affiliations
- PMID: 10951581
- DOI: 10.1038/sj.onc.1203722
pRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels
H Jiang et al. Oncogene. 2000.
Abstract
A key difference among the three structurally similar pRB family members is that only pRB is a tumor suppressor. Identification of distinctive functional differences between pRB and p107/p130 therefore holds promise for a better understanding of the tumor suppression mechanisms of pRB. Enigmatically, pRB and p107 have been shown to have indistinguishable growth suppression activities when studied in the pRB-deficient Saos-2 cell system. In this study, we discovered that, when expressed at physiologically relevant levels, pRB and p107 had distinctive effects in causing growth suppression. pRB induced cellular p130 levels while p107 repressed them. p107, but not pRB, blocked cells inside S phase in addition to G1 arrest. In contrast, no qualitative differences were identified in their abilities to repress the expression of a set of suspected pRB/E2F repression target genes. These results indicate that pRB and p107 possess different growth suppression effects, despite the fact that they have similar E2F repression effects.
Similar articles
- The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB, Rutka JT, Hubbard SL, Mondal S, Hamel PA. Dirks PB, et al. Oncogene. 1998 Aug 20;17(7):867-76. doi: 10.1038/sj.onc.1202008. Oncogene. 1998. PMID: 9780003 - Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M, Gill RM, Hamel PA. Kiess M, et al. Cell Growth Differ. 1995 Oct;6(10):1287-98. Cell Growth Differ. 1995. PMID: 8845306 - Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M, Gill RM, Wong AK, Hamel PA. Sidle A, et al. Crit Rev Biochem Mol Biol. 1996 Jun;31(3):237-71. doi: 10.3109/10409239609106585. Crit Rev Biochem Mol Biol. 1996. PMID: 8817077 Review. - Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta.
Hu X, Zuckerman KS. Hu X, et al. Leuk Lymphoma. 2000 Jul;38(3-4):235-46. doi: 10.3109/10428190009087015. Leuk Lymphoma. 2000. PMID: 10830731 Review.
Cited by
- An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1.
Qin A. Qin A. Front Oncol. 2023 Apr 27;13:1173467. doi: 10.3389/fonc.2023.1173467. eCollection 2023. Front Oncol. 2023. PMID: 37182173 Free PMC article. Review. - Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family.
Liban TJ, Thwaites MJ, Dick FA, Rubin SM. Liban TJ, et al. J Mol Biol. 2016 Oct 9;428(20):3960-3971. doi: 10.1016/j.jmb.2016.08.017. Epub 2016 Aug 25. J Mol Biol. 2016. PMID: 27567532 Free PMC article. - RGS16, a novel p53 and pRb cross-talk candidate inhibits migration and invasion of pancreatic cancer cells.
Carper MB, Denvir J, Boskovic G, Primerano DA, Claudio PP. Carper MB, et al. Genes Cancer. 2014 Nov;5(11-12):420-35. doi: 10.18632/genesandcancer.43. Genes Cancer. 2014. PMID: 25568667 Free PMC article. - Regulation of human RNA polymerase III transcription by DNMT1 and DNMT3a DNA methyltransferases.
Selvakumar T, Gjidoda A, Hovde SL, Henry RW. Selvakumar T, et al. J Biol Chem. 2012 Mar 2;287(10):7039-50. doi: 10.1074/jbc.M111.285601. Epub 2012 Jan 4. J Biol Chem. 2012. PMID: 22219193 Free PMC article. - p107 in the public eye: an Rb understudy and more.
Wirt SE, Sage J. Wirt SE, et al. Cell Div. 2010 Apr 2;5:9. doi: 10.1186/1747-1028-5-9. Cell Div. 2010. PMID: 20359370 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical